Evidence map›Paper›PMID 35631475›Full record

ArticlePharmaceutics2022

Fast In Vitro Release and In Vivo Absorption of an Anti-Schizophrenic Drug Paliperidone from Its Soluplus

Ye Zhou, Chenhui Wang, Wenqian Liu, Meiqing Yang, Bohui Xu, Yong Chen

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ye ZhouSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Chenhui WangSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Wenqian LiuSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Meiqing YangSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Bohui XuSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Yong ChenSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, China.
Nantong University · CN

Funding

Nantong Science and Technology Bureau JC2021117National Natural Science Foundation of China 81603044
6 · The paper itself

Abstract

The purpose of this study was to develop a drug delivery system for paliperidone (PPD) in order to provide a more effective therapeutic strategy for patients with acute schizophrenia. PPD-loaded Soluplus

Indexed as

acute schizophreniamicellespaliperidonepharmacokineticsSoluplus®TPGS

Identifiers

PMID35631475
PMCPMC9147083
OpenAlexW4224243175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.